| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 4682838
[patent_doc_number] => 20080249064
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-09
[patent_title] => 'Activities of an active principle obtained from powdered alfalfa seeds (Medicago sativa), active principle used and process of obtaining the same'
[patent_app_type] => utility
[patent_app_number] => 11/902836
[patent_app_country] => US
[patent_app_date] => 2007-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 3336
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0249/20080249064.pdf
[firstpage_image] =>[orig_patent_app_number] => 11902836
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/902836 | Activities of an active principle obtained from powdered alfalfa seeds (Medicago sativa), active principle used and process of obtaining the same | Sep 25, 2007 | Abandoned |
Array
(
[id] => 4705133
[patent_doc_number] => 20080064657
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-03-13
[patent_title] => 'Isomaltooligosaccharides from Leuconostoc as Neutraceuticals'
[patent_app_type] => utility
[patent_app_number] => 11/860845
[patent_app_country] => US
[patent_app_date] => 2007-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 9926
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0064/20080064657.pdf
[firstpage_image] =>[orig_patent_app_number] => 11860845
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/860845 | Isomaltooligosaccharides from Leuconostoc as Neutraceuticals | Sep 24, 2007 | Abandoned |
Array
(
[id] => 5398309
[patent_doc_number] => 20090318372
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-24
[patent_title] => 'Method For Producing 2-O-Glyceryl-Alpha-D-Glucopyranoside'
[patent_app_type] => utility
[patent_app_number] => 12/442288
[patent_app_country] => US
[patent_app_date] => 2007-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 6074
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0318/20090318372.pdf
[firstpage_image] =>[orig_patent_app_number] => 12442288
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/442288 | Method For Producing 2-O-Glyceryl-Alpha-D-Glucopyranoside | Sep 20, 2007 | Abandoned |
Array
(
[id] => 4939414
[patent_doc_number] => 20080076733
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-03-27
[patent_title] => 'Pharmaceutical compositions and therapeutic applications for the use of a novel vitamin B12 derivative, N-acetyl-L-cysteinylcobalamin'
[patent_app_type] => utility
[patent_app_number] => 11/903066
[patent_app_country] => US
[patent_app_date] => 2007-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 17413
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0076/20080076733.pdf
[firstpage_image] =>[orig_patent_app_number] => 11903066
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/903066 | Pharmaceutical compositions and therapeutic applications for the use of a novel vitamin B12 derivative, N-acetyl-L-cysteinylcobalamin | Sep 19, 2007 | Issued |
Array
(
[id] => 4933462
[patent_doc_number] => 20080004237
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-01-03
[patent_title] => 'Polysacchocride prodrug of 5-fluorouracil (5-FU) with enhanced target specificity for galectin-3 expressing cancers'
[patent_app_type] => utility
[patent_app_number] => 11/657754
[patent_app_country] => US
[patent_app_date] => 2007-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 7172
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0004/20080004237.pdf
[firstpage_image] =>[orig_patent_app_number] => 11657754
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/657754 | Polysacchocride prodrug of 5-fluorouracil (5-FU) with enhanced target specificity for galectin-3 expressing cancers | Sep 16, 2007 | Abandoned |
Array
(
[id] => 5398321
[patent_doc_number] => 20090318384
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-24
[patent_title] => 'COMPOSITION INTENDED FOR THE TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS'
[patent_app_type] => utility
[patent_app_number] => 12/441808
[patent_app_country] => US
[patent_app_date] => 2007-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 2895
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0318/20090318384.pdf
[firstpage_image] =>[orig_patent_app_number] => 12441808
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/441808 | COMPOSITION INTENDED FOR THE TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS | Sep 16, 2007 | Abandoned |
Array
(
[id] => 4705343
[patent_doc_number] => 20080064867
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-03-13
[patent_title] => 'PROCESS FOR THE SYNTHESIS OF OLIGONUCLEOTIDES'
[patent_app_type] => utility
[patent_app_number] => 11/853662
[patent_app_country] => US
[patent_app_date] => 2007-09-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 27124
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0064/20080064867.pdf
[firstpage_image] =>[orig_patent_app_number] => 11853662
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/853662 | Process for the synthesis of oligonucleotides | Sep 10, 2007 | Issued |
Array
(
[id] => 6444442
[patent_doc_number] => 20100144654
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-06-10
[patent_title] => 'Crystalline forms of 1,6-Bis [3-(3-carboxymethylphenyl)-4-(2-alpha-D-mannopyranosyl-oxy)-phenyl] hexane'
[patent_app_type] => utility
[patent_app_number] => 12/440300
[patent_app_country] => US
[patent_app_date] => 2007-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 16046
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0144/20100144654.pdf
[firstpage_image] =>[orig_patent_app_number] => 12440300
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/440300 | Crystalline forms of 1,6-Bis [3-(3-carboxymethylphenyl)-4-(2-alpha-D-mannopyranosyl-oxy)-phenyl] hexane | Sep 6, 2007 | Abandoned |
Array
(
[id] => 4939594
[patent_doc_number] => 20080076913
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-03-27
[patent_title] => 'Methods of synthesizing oligonucleotides using carbonate protecting groups and alpha-effect nucleophile deprotection'
[patent_app_type] => utility
[patent_app_number] => 11/899828
[patent_app_country] => US
[patent_app_date] => 2007-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 12019
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0076/20080076913.pdf
[firstpage_image] =>[orig_patent_app_number] => 11899828
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/899828 | Methods of synthesizing oligonucleotides using carbonate protecting groups and alpha-effect nucleophile deprotection | Sep 5, 2007 | Issued |
Array
(
[id] => 7724440
[patent_doc_number] => 08097711
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-01-17
[patent_title] => 'Thioether substituted aryl carbonate protecting groups'
[patent_app_type] => utility
[patent_app_number] => 11/897898
[patent_app_country] => US
[patent_app_date] => 2007-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 6
[patent_no_of_words] => 24830
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/097/08097711.pdf
[firstpage_image] =>[orig_patent_app_number] => 11897898
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/897898 | Thioether substituted aryl carbonate protecting groups | Aug 30, 2007 | Issued |
Array
(
[id] => 4771414
[patent_doc_number] => 20080057072
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-03-06
[patent_title] => 'ANTAGONISTS OF CI-M6P/IGF2R FOR PREVENTION AND TREATMENT OF CTGF-MEDIATED OCULAR DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 11/847523
[patent_app_country] => US
[patent_app_date] => 2007-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5064
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0057/20080057072.pdf
[firstpage_image] =>[orig_patent_app_number] => 11847523
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/847523 | ANTAGONISTS OF CI-M6P/IGF2R FOR PREVENTION AND TREATMENT OF CTGF-MEDIATED OCULAR DISORDERS | Aug 29, 2007 | Abandoned |
Array
(
[id] => 4880392
[patent_doc_number] => 20080153775
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-06-26
[patent_title] => 'WEIGHT REDUCTION PROGRAM AND METHOD'
[patent_app_type] => utility
[patent_app_number] => 11/845131
[patent_app_country] => US
[patent_app_date] => 2007-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 3057
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0153/20080153775.pdf
[firstpage_image] =>[orig_patent_app_number] => 11845131
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/845131 | WEIGHT REDUCTION PROGRAM AND METHOD | Aug 26, 2007 | Abandoned |
Array
(
[id] => 6511562
[patent_doc_number] => 20100261272
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-10-14
[patent_title] => 'Compositions for Reducing Cell Adhesion to Bubbles'
[patent_app_type] => utility
[patent_app_number] => 12/438681
[patent_app_country] => US
[patent_app_date] => 2007-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 9232
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0261/20100261272.pdf
[firstpage_image] =>[orig_patent_app_number] => 12438681
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/438681 | Compositions for reducing cell adhesion to bubbles | Aug 26, 2007 | Issued |
Array
(
[id] => 4734388
[patent_doc_number] => 20080051368
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-02-28
[patent_title] => 'Process for the isolation and stabilization of low-molecular weight aminoglycans form waste egg shells'
[patent_app_type] => utility
[patent_app_number] => 11/895500
[patent_app_country] => US
[patent_app_date] => 2007-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3383
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0051/20080051368.pdf
[firstpage_image] =>[orig_patent_app_number] => 11895500
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/895500 | Process for the isolation and stabilization of low-molecular weight aminoglycans form waste egg shells | Aug 26, 2007 | Issued |
Array
(
[id] => 5231325
[patent_doc_number] => 20070293433
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-12-20
[patent_title] => 'Methods of treating aging of skin with oligosaccharides in cosmetic or dermatological compositions that stimulate adhesion of keratinocytes to major proteins of the dermoepidermal junction and restore epidermal cohesion'
[patent_app_type] => utility
[patent_app_number] => 11/894945
[patent_app_country] => US
[patent_app_date] => 2007-08-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 3952
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0293/20070293433.pdf
[firstpage_image] =>[orig_patent_app_number] => 11894945
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/894945 | Methods of treating aging of skin with oligosaccharides in cosmetic or dermatological compositions that stimulate adhesion of keratinocytes to major proteins of the dermoepidermal junction and restore epidermal cohesion | Aug 21, 2007 | Abandoned |
Array
(
[id] => 4803566
[patent_doc_number] => 20080015155
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-01-17
[patent_title] => 'Compositions and Methods for the Treatment of Inflammatory Conditions of the Mucosae, Skin and the Eye'
[patent_app_type] => utility
[patent_app_number] => 11/841564
[patent_app_country] => US
[patent_app_date] => 2007-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7991
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0015/20080015155.pdf
[firstpage_image] =>[orig_patent_app_number] => 11841564
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/841564 | Compositions and Methods for the Treatment of Inflammatory Conditions of the Mucosae, Skin and the Eye | Aug 19, 2007 | Abandoned |
Array
(
[id] => 6644311
[patent_doc_number] => 20100227834
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-09
[patent_title] => 'NUCLEOSIDES FOR SUPPRESSING OR REDUCING THE DEVELOPMENT OF RESISTANCE IN CYTOSTATIC THERAPY'
[patent_app_type] => utility
[patent_app_number] => 12/377239
[patent_app_country] => US
[patent_app_date] => 2007-08-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 27393
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0227/20100227834.pdf
[firstpage_image] =>[orig_patent_app_number] => 12377239
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/377239 | Nucleosides for suppressing or reducing the development of resistance in cytostatic therapy | Aug 12, 2007 | Issued |
Array
(
[id] => 853123
[patent_doc_number] => 07378508
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-05-27
[patent_title] => 'Polymorphic crystalline forms of tiacumicin B'
[patent_app_type] => utility
[patent_app_number] => 11/831886
[patent_app_country] => US
[patent_app_date] => 2007-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 12898
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/378/07378508.pdf
[firstpage_image] =>[orig_patent_app_number] => 11831886
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/831886 | Polymorphic crystalline forms of tiacumicin B | Jul 30, 2007 | Issued |
Array
(
[id] => 4688977
[patent_doc_number] => 20080033158
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-02-07
[patent_title] => 'Multi layer chromatography of nucleic acids'
[patent_app_type] => utility
[patent_app_number] => 11/888490
[patent_app_country] => US
[patent_app_date] => 2007-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 4966
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0033/20080033158.pdf
[firstpage_image] =>[orig_patent_app_number] => 11888490
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/888490 | Multi layer chromatography of nucleic acids | Jul 30, 2007 | Issued |
Array
(
[id] => 5199702
[patent_doc_number] => 20070299020
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-12-27
[patent_title] => 'Methods for treatment of ovarian, colorectal or pancreatic cancer using 4-(aminno)-2(2,6-dioxo(3-piperidyl)-isoindoline-1,3-dione'
[patent_app_type] => utility
[patent_app_number] => 11/881756
[patent_app_country] => US
[patent_app_date] => 2007-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 20185
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0299/20070299020.pdf
[firstpage_image] =>[orig_patent_app_number] => 11881756
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/881756 | Methods for treatment of ovarian, colorectal or pancreatic cancer using 4-(aminno)-2(2,6-dioxo(3-piperidyl)-isoindoline-1,3-dione | Jul 26, 2007 | Abandoned |